Does METOPROLOL Cause Patent ductus arteriosus? 104 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 104 reports of Patent ductus arteriosus have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.3% of all adverse event reports for METOPROLOL.
104
Reports of Patent ductus arteriosus with METOPROLOL
0.3%
of all METOPROLOL reports
3
Deaths
20
Hospitalizations
How Dangerous Is Patent ductus arteriosus From METOPROLOL?
Of the 104 reports, 3 (2.9%) resulted in death, 20 (19.2%) required hospitalization, and 5 (4.8%) were considered life-threatening.
Is Patent ductus arteriosus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 104 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Patent ductus arteriosus?
ONDANSETRON (185)
LAMOTRIGINE (168)
PAROXETINE (168)
ACETAMINOPHEN (154)
VENLAFAXINE (135)
SERTRALINE (130)
LEVETIRACETAM (122)
FLUOXETINE (107)
RAMIPRIL (98)
IBUPROFEN (95)
Which METOPROLOL Alternatives Have Lower Patent ductus arteriosus Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE